Point72 »

Y Mabs Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-03-31 $240k 15k 16.26

More positions owned by Point72

Target Corporation Call Option (TGT)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Oracle Corporation (ORCL)
Wal-Mart Stores (WMT)
Raytheon Technologies Corp Call Option (RTX)
Lockheed Martin Corporation Call Option (LMT)
Adobe Systems Incorporated (ADBE)
General Motors Company (GM)
Eli Lilly & Co. Call Option (LLY)
Netflix Call Option (NFLX)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
UnitedHealth (UNH)
At&t Call Option (T)
Nextera Energy Call Option (NEE)

View all positions for Point72

Top funds holding Y Mabs Therapeutics

BlackRock
Paradigm Biocapital Advisors
Sofinnova Ventures
Vanguard Group
Polar Capital Holdings
Point72 Asset Management
D. E. Shaw & Co
State Street Corporation
Pictet Asset Management Holding SA
Geode Capital Management
Acadian Asset Management
Caligan Partners
Soleus Capital Management
Dimensional Fund Advisors
Goldman Sachs Group

View all funds holding Y Mabs Therapeutics